BlueOcean NutraSciences To Present Its CO2 Foliar Spray at the NCN Las Vegas Investor Day September 26, 2017
September 21, 2017 (Source) — BlueOcean NutraSciences Inc. (TSXV:BOC) (“BlueOcean” or the “Company”) is pleased to announce that the Company was selected to present at Nutrition Capital Network’s (NCN) Natural Products Technology Conference for Investors in Las Vegas on September 26 during the Supply Side West Show at Mandalay Bay.
The Company’s revived CO2 gas infusion business now targets greenhouse plant growers since filing for a US PTO CO2 Foliar Spray Technology Patent in August 2017. The Company expects 1) a reduction of 50% of CO2 gassing volume in greenhouses that switch to targeted CO2 foliar spray at similar levels of required CO2 in PPM onto plant leaves and 2) increased plants yields due to precise adjustment of CO2 at desired PPM during plant grow phases.
Foliar spray has been in use for about 50 years in greenhouses but no one has to date, dissolved natural CO2 into water without bubbles for foliar spray use. The Company’s revived CO2 technology is targeted at the $340Bn Global Greenhouse Vegetables market, the $14Bn US Indoor grow market and the $7Bn US and Canadian Cannabis markets.
The Company’s presentation deck describing the opportunity for CO2 foliar spray is now available on the company’s website www.blueoceannutra.ca under Investors – Investor Materials – CO2 Grow Solutions Presentation.
About Nutrition Capital Network (NCN)
San Francisco based NCN connects investors with high-potential growth companies in the nutrition and health and wellness industry. NCN also provides cutting edge research based industry knowledge and serves as a gateway to connections, insights and resources. Since 2007, 545 companies have presented at 31 NCN investor meetings in the US and the EU.
Get our daily investorintel update
BlueOcean NutraSciences Inc. is a Canadian public listed company (TSXV:BOC) whose mission is to develop effective, innovative and sustainable products from Natural Sources, to improve the lives of its customers. This includes naturally accelerating plant growth. BlueOcean’s first specialty ingredient is its patent protected shrimp oil which is the base for its current three consumer brands. Shrimp oil is made from sustainably certified North Atlantic cold water shrimp shells (the by-product of the cooked and peeled shrimp process) and contains phospholipid bound omega- fatty acids and over 40 times more natural astaxanthin compared to krill oil ingredients.
Shrimp oil’s unique nutritional properties enables the ingredient to make numerous health claims across a wide range of markets, including the $4Bn omega-3 heart health market, the $9Bn joint health market and the $10Bn sports supplement market. BlueOcean markets its shrimp oil ingredient through a number of consumer brands that are formulated to target these specific markets.
BlueOcean currently markets its shrimp oil under three consumer brands: Pure Polar(R) Omega-3 Shrimp Oil, Joint AXTM and Sport AXTM. Products may be purchased online at purepolarlabs.com
Its CO2 gas infusion technology is being commercialized and monetized with 10% of the license offered for sale for C$1M. The Company expects to save about $1M per average 500,000 sq foot greenhouse from a 50% CO2 gassing cost reduction and higher crop yields. The CO2 foliar spray technology is targeted at the $340Bn Global Greenhouse Vegetables market, the $14Bn US Indoor grow market and the $7Bn US and Canadian Cannabis markets. There are no patents issued by the USPTO for applying natural liquid CO2 to plants via foliar spray.
This news release may contain forward-looking statements that are based on BlueOcean’s expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
InvestorIntel is a trusted source of reliable information at the forefront of emerging markets that brings investment opportunities to discerning investors.